To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene FLVCR2andTTLL5andC14orf179TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
722 representative clones for gene FLVCR2andTTLL5andC14orf179 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AK309748   .a 1 to 4168 1 to 4168 I499V R531G V593A D723G S1125G ... tiling clone,   4168/4168
(100 %)
7 diff
(99.9 %id)
DB494211 hypothalamus .a 1102 to 1597 1 to 496       496/496
(100 %)
2 diff
(99.6 %id)
DA089362 cerebellum .a 1240 to 1806 2 to 568   tiling clone, capped   567/567
(100 %)
0 diff
(100 %id)
DB049192 testis .a 2849 to 3412 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
AW408411 lymph .a 2855 to 3311 1 to 457       457/457
(100 %)
6 diff
(98.7 %id)
TI_154148037   .a 2862 to 3434 223 to 794       572/695
(82 %)
11 diff
(98.5 %id)
DB007940 cervix, tumor tissue .a 2872 to 3437 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
BG540113 lung .a 2885 to 3580 11 to 707       697/707
(98 %)
9 diff
(98.8 %id)
BP339285 Spleen .a 3074 to 3634 1 to 561   tiling clone,   561/561
(100 %)
3 diff
(99.5 %id)
BY797223 eye .b 1 to 124 1 to 124   tiling clone,   124/124
(100 %)
0 diff
(100 %id)
BX491053   .b 119 to 600 1 to 482   tiling clone,   482/482
(100 %)
4 diff
(99.2 %id)
NM_015072.4   .b 214 to 4970 1 to 4757 exact RefSeq, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 4757/4757
(100 %)
0 diff
(100 %id)
DA195275 amygdala .b 215 to 776 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DB087203 testis .b 228 to 801 2 to 581   capped   580/580
(100 %)
7 diff
(98.8 %id)
DA776016 brain .b 240 to 569 2 to 582   capped   581/581
(100 %)
1 diff
(99.9 %id)
DA888196   .b 240 to 815 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
AL701771 human skeletal muscle .b 242 to 424 1 to 183       183/183
(100 %)
0 diff
(100 %id)
TI_44350621   .b 247 to 992 117 to 875       759/1269
(59 %)
32 diff
(97.5 %id)
BI561656 testis .b 251 to 992 1 to 755       755/1149
(65 %)
29 diff
(97.5 %id)
BG722056 testis .b 259 to 950 1 to 692       692/692
(100 %)
4 diff
(99.5 %id)
DA249075 brain .b 261 to 854 2 to 597   capped   596/598
(99 %)
5 diff
(99.2 %id)
DB449574 testis .b 262 to 958 1 to 695       695/699
(99 %)
8 diff
(98.9 %id)
DA185848 amygdala .b 265 to 835 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA221657 brain .b 265 to 818 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DA242574 brain .b 271 to 861 2 to 592   capped   591/601
(98 %)
1 diff
(99.9 %id)
DB081844 testis .b 273 to 812 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
DA193477 amygdala .b 275 to 872 2 to 599   capped   598/598
(100 %)
0 diff
(100 %id)
DA758878   .b 275 to 829 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DB071757 testis .b 275 to 828 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DB079189 testis .b 275 to 626 2 to 353   capped   352/352
(100 %)
2 diff
(99.5 %id)
DB088075 testis .b 275 to 836 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DB205010 trachea .b 275 to 853 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
DB239336 trachea .b 275 to 781 2 to 508   capped   507/507
(100 %)
0 diff
(100 %id)
DB080666 testis .b 276 to 845 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DB007784 cervix, tumor tissue .b 277 to 842 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DB061421 testis .b 277 to 760 2 to 485   capped   484/484
(100 %)
1 diff
(99.8 %id)
DB062561 testis .b 277 to 809 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
DB069296 testis .b 277 to 830 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DB069929 testis .b 277 to 817 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
DB070010 testis .b 277 to 815 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DB097189 testis .b 277 to 669 2 to 394   capped   393/397
(98 %)
2 diff
(99.5 %id)
DB097683 testis .b 277 to 854 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DB089521 testis .b 278 to 840 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
BG717738 testis .b 280 to 958 1 to 689   AAA   689/1052
(65 %)
29 diff
(97.3 %id)
BG718147 testis .b 281 to 748 1 to 480       478/523
(91 %)
22 diff
(95.8 %id)
AY237126 testis .b 284 to 4966 1 to 4683 A149V F1267S tiling clone,   4683/4683
(100 %)
2 diff
(100.0 %id)
DB066681 testis .b 285 to 812 2 to 529   capped   528/528
(100 %)
1 diff
(99.9 %id)
DB457720 testis .b 286 to 754 1 to 471       471/474
(99 %)
4 diff
(99.2 %id)
AL110381 testis .b 292 to 983 1 to 692       692/692
(100 %)
0 diff
(100 %id)
DB071719 testis .b 292 to 835 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DB276757 uterus .b 292 to 830 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
CN360770 embryonic stem cells, cell lines H1, H7, andH9 .b 293 to 537 1 to 245       245/245
(100 %)
2 diff
(99.2 %id)
DB727780 testis .b 295 to 1007 1 to 713       713/713
(100 %)
11 diff
(98.5 %id)
BX642977   .b 296 to 855 1 to 560       560/560
(100 %)
4 diff
(99.3 %id)
DA797165 brain .b 296 to 852 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
BE393669 endometrium, adenocarcinoma cell line, uterus .b 303 to 961 1 to 659   available from MGC,   659/707
(93 %)
12 diff
(98.4 %id)
DB067198 testis .b 305 to 820 2 to 517   capped   516/516
(100 %)
0 diff
(100 %id)
BC136472 Testicle, PCR rescued clones .b 324 to 4648 1 to 4324 exact tiling clone,   4324/4324
(100 %)
1 diff
(100.0 %id)
BC136473 Brain, cerebellum, PCR rescued clones .b 324 to 4653 1 to 4330 A149V     4330/4330
(100 %)
1 diff
(100.0 %id)
TI_1971553611   .b 324 to 1143 173 to 992     Submitted on the opposite strand 820/1233
(66 %)
16 diff
(98.8 %id)
TI_2016730515   .b 324 to 1330 86 to 1087       1002/1250
(80 %)
6 diff
(99.6 %id)
TI_2016730807   .b 324 to 1319 86 to 1078       993/1264
(78 %)
10 diff
(99.3 %id)
DR000776 fetal brain .b 346 to 1071 9 to 735       727/737
(98 %)
10 diff
(98.7 %id)
BE294216 muscle, rhabdomyosarcoma .b 398 to 1068 1 to 670       670/708
(94 %)
13 diff
(98.2 %id)
CV026270 mixed .b 489 to 1055 1 to 567       567/567
(100 %)
2 diff
(99.7 %id)
DB068137 testis .b 630 to 1176 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
AB023215 brain .b 654 to 4966 1 to 4313   available from KIAA,   4313/4313
(100 %)
2 diff
(100.0 %id)
CN360771 embryonic stem cells, cell lines H1, H7, andH9 .b 681 to 1401 1 to 721       721/721
(100 %)
0 diff
(100 %id)
TI_2016724083   .b 689 to 1280 12 to 604       593/604
(98 %)
9 diff
(98.6 %id)
TI_2016728755   .b 692 to 1769 11 to 1081   AAA   1071/1246
(85 %)
17 diff
(98.7 %id)
TI_1971553615   .b 693 to 1671 14 to 994       981/1012
(96 %)
17 diff
(98.4 %id)
TI_2016728399   .b 753 to 1740 995 to 15       981/1217
(80 %)
9 diff
(99.3 %id)
BM194121 leukopheresis .b 798 to 1352 1 to 555       555/555
(100 %)
2 diff
(99.7 %id)
CF136830 lymph .b 800 to 1334 1 to 535       535/535
(100 %)
3 diff
(99.5 %id)
TI_154166061   .b 806 to 1421 79 to 699       621/800
(77 %)
6 diff
(99.3 %id)
BQ304823 breast .b 807 to 971 168 to 2       167/168
(99 %)
0 diff
(100 %id)
TI_2016728397   .b 863 to 2196 1294 to 17       1174/1297
(90 %)
33 diff
(97.5 %id)
AA614255   .b 864 to 1265 426 to 25       402/426
(94 %)
0 diff
(100 %id)
DA240402 brain .b 872 to 1465 2 to 596   capped   595/595
(100 %)
1 diff
(99.9 %id)
DB293083   .b 897 to 1704 2 to 812   capped   809/816
(99 %)
8 diff
(99.1 %id)
DA409632 thalamus .b 900 to 1448 2 to 552   capped   551/551
(100 %)
4 diff
(99.3 %id)
DB070896 testis .b 900 to 1389 2 to 491   capped   490/490
(100 %)
1 diff
(99.8 %id)
DB071245 testis .b 900 to 1431 2 to 533   capped   532/532
(100 %)
1 diff
(99.9 %id)
DB092629 testis .b 902 to 1455 2 to 556   capped   555/555
(100 %)
2 diff
(99.7 %id)
DB087645 testis .b 999 to 1508 2 to 511   capped   510/510
(100 %)
1 diff
(99.9 %id)
TI_2016729059   .b 1031 to 2174 1 to 1138       1138/1290
(88 %)
14 diff
(99.0 %id)
DB063673 testis .b 1117 to 1660 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
TI_2016728479   .b 1161 to 2313 9 to 1152       1144/1280
(89 %)
20 diff
(98.5 %id)
TI_2016724131   .b 1183 to 1728 560 to 16       545/560
(97 %)
0 diff
(100 %id)
TI_1971553619   .b 1227 to 2399 16 to 1178       1163/1206
(96 %)
46 diff
(96.2 %id)
TI_2016724123   .b 1227 to 1732 13 to 519       507/519
(97 %)
7 diff
(98.7 %id)
BF377155 testis_normal .b 1234 to 1524 307 to 15       293/308
(95 %)
3 diff
(99.1 %id)
DB153531 thymus .b 1264 to 1834 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DB230120 trachea .b 1268 to 1740 2 to 474   capped   473/473
(100 %)
0 diff
(100 %id)
DA449715 tongue, tumor tissue .b 1293 to 1867 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
BE303008 melanotic melanoma, skin .b 1307 to 1835 1 to 529       529/529
(100 %)
3 diff
(99.5 %id)
BE729230 melanotic melanoma, skin .b 1323 to 2043 1 to 723       721/749
(96 %)
13 diff
(98.3 %id)
DB092458 testis .b 1357 to 1909 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
BE076546 breast .b 1427 to 1953 536 to 4     Submitted on the opposite strand 533/545
(97 %)
22 diff
(96.0 %id)
DB100226 testis .b 1478 to 2062 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
BG424149 Kidney, renal cell adenocarcinoma .b 1502 to 1976 1 to 501       501/502
(99 %)
26 diff
(94.9 %id)
DA783316 brain .b 1506 to 2029 2 to 525   capped   524/524
(100 %)
1 diff
(99.9 %id)
BM144401 leukopheresis .b 1528 to 1982 455 to 1       455/455
(100 %)
0 diff
(100 %id)
TI_2016724077   .b 1581 to 2189 1 to 611       611/639
(95 %)
12 diff
(98.2 %id)
TI_2016724137   .b 1584 to 2099 1 to 517       517/517
(100 %)
7 diff
(98.7 %id)
AW500639 lymph .b 1624 to 2133 8 to 517       510/517
(98 %)
6 diff
(98.9 %id)
TI_154154910   .b 1624 to 2289 80 to 743       664/667
(99 %)
15 diff
(97.8 %id)
BC016625 Eye, retinoblastoma .b 1633 to 3639 1 to 2007   available from MGC, AAA   2007/2114
(94 %)
0 diff
(100 %id)
BE779879 eye, retinoblastoma .b 1650 to 2359 1 to 711   available from MGC,   711/989
(71 %)
35 diff
(96.5 %id)
W27895 eye, retina .b 1676 to 2087 36 to 451       416/519
(80 %)
4 diff
(99.3 %id)
BP236406 coronary artery .b 1713 to 2299 1 to 588       588/588
(100 %)
3 diff
(99.5 %id)
DA739818   .b 1730 to 2271 2 to 544   capped   543/543
(100 %)
2 diff
(99.7 %id)
BQ432388 melanotic melanoma, skin .b 1836 to 2497 12 to 685       674/841
(80 %)
21 diff
(97.6 %id)
BE011620 breast_normal .b 1845 to 2007 1 to 165       165/165
(100 %)
2 diff
(98.8 %id)
BG770527 melanotic melanoma, high MDR (cell line), skin .b 1870 to 2701 1 to 807       805/893
(90 %)
78 diff
(91.3 %id)
TI_2016724079   .b 1909 to 2658 9 to 758       750/758
(98 %)
7 diff
(99.1 %id)
BP293204 lung .b 1936 to 2542 1 to 607       607/607
(100 %)
1 diff
(99.9 %id)
CB144357 Liver .b 1937 to 2566 1 to 630       630/630
(100 %)
0 diff
(100 %id)
BG767299 melanotic melanoma, high MDR (cell line), skin .b 1952 to 2417 88 to 554       467/554
(84 %)
10 diff
(98.2 %id)
TI_2016724125   .b 1977 to 2444 483 to 16       468/483
(96 %)
2 diff
(99.6 %id)
BE011661 breast_normal .b 1992 to 2127 1 to 136       136/136
(100 %)
1 diff
(99.3 %id)
BF082504 breast .b 2063 to 2499 1 to 436       436/442
(98 %)
10 diff
(97.8 %id)
BE926473 breast .b 2081 to 2499 1 to 418       418/424
(98 %)
4 diff
(99.1 %id)
BE693632 breast .b 2095 to 2499 16 to 420       405/426
(95 %)
9 diff
(97.9 %id)
BE693634 breast .b 2116 to 2466 353 to 5       349/353
(98 %)
0 diff
(100 %id)
BE693639 breast .b 2116 to 2459 360 to 16       345/360
(95 %)
0 diff
(100 %id)
BP361489 thalamus .b 2201 to 2775 1 to 578       576/583
(98 %)
8 diff
(98.7 %id)
AA320061 adipose tissue, white .b 2259 to 2563 1 to 306       306/308
(99 %)
2 diff
(99.4 %id)
BF846078 lung_normal .b 2386 to 2775 38 to 428       391/452
(86 %)
9 diff
(98.1 %id)
DA761430 tongue .b 2426 to 2947 2 to 523   capped   522/522
(100 %)
0 diff
(100 %id)
TI_2016724129   .b 2429 to 3058 11 to 640       630/641
(98 %)
9 diff
(98.6 %id)
DA484603 brain .b 2444 to 3001 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
BE295638 muscle, rhabdomyosarcoma .b 2464 to 2996 1 to 538       538/545
(98 %)
6 diff
(98.9 %id)
DA985385 synovial membrane tissue from rheumatioidarthritis .b 2467 to 3034 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA082625 cerebellum .b 2483 to 3068 2 to 588   capped   587/587
(100 %)
2 diff
(99.7 %id)
DB325985 brain .b 2513 to 3058 548 to 3       546/548
(99 %)
1 diff
(99.9 %id)
BG167948 hypernephroma, cell line, Kidney .b 2621 to 3425 1 to 812       812/908
(89 %)
33 diff
(96.4 %id)
AV735046 pheochromocytoma .b 2635 to 3025 1 to 384       389/388
(100 %)
8 diff
(98.0 %id)
BG679070 skin, squamous cell carcinoma .b 2677 to 3452 1 to 775       775/775
(100 %)
2 diff
(99.8 %id)
DA269484 caudate nucleus .b 2686 to 3325 2 to 641   capped   640/640
(100 %)
0 diff
(100 %id)
DB026571 testis .b 2759 to 3310 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
TI_2016724085   .b 2821 to 3379 1 to 558       558/558
(100 %)
7 diff
(98.8 %id)
BQ376623 testis_normal .b 2912 to 3162 252 to 1       252/252
(100 %)
10 diff
(96.1 %id)
BG113561 Bone, osteosarcoma, cell line .b 2964 to 3662 1 to 704       704/1054
(66 %)
15 diff
(98.6 %id)
DB232287 trachea .b 3026 to 3488 2 to 464   capped   463/463
(100 %)
0 diff
(100 %id)
TI_159697262   .b 3161 to 4110 975 to 39       937/1090
(85 %)
18 diff
(98.4 %id)
TI_1971553621   .b 3227 to 4176 5 to 954       950/954
(99 %)
18 diff
(98.2 %id)
CF145797 CNCAP(3)T-225 cell line, Prostate .b 3350 to 4067 1 to 716       716/716
(100 %)
9 diff
(98.8 %id)
TI_154178074   .b 3357 to 4132 70 to 841       772/917
(84 %)
17 diff
(98.2 %id)
TI_2016728401   .b 3370 to 4429 1053 to 5       1049/1256
(83 %)
10 diff
(99.3 %id)
CN358576 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 3475 to 4132 1 to 657       657/657
(100 %)
2 diff
(99.7 %id)
R13157 whole brain .b 3492 to 3825 1 to 337       337/390
(86 %)
11 diff
(97.2 %id)
TI_2016728549   .b 3548 to 4656 1 to 1107       1107/1258
(87 %)
12 diff
(99.1 %id)
TI_2016724135   .b 3550 to 3988 1 to 439       439/439
(100 %)
8 diff
(98.2 %id)
BM724412 eye, fetal eye .b 3550 to 4204 1 to 655       655/655
(100 %)
4 diff
(99.4 %id)
TI_2016724081   .b 3551 to 4105 1 to 557       557/559
(99 %)
12 diff
(97.9 %id)
TI_2016728657   .b 3556 to 4639 8 to 1085       1078/1259
(85 %)
15 diff
(98.9 %id)
BI014474 lung_tumor .b 3626 to 4160 13 to 547       535/547
(97 %)
6 diff
(99.0 %id)
BG437657 large cell carcinoma, lung .b 3639 to 4318 1 to 679       679/791
(85 %)
9 diff
(98.9 %id)
BG205496   .b 3655 to 4319 1 to 664       664/779
(85 %)
27 diff
(96.6 %id)
TI_1971555131   .b 3658 to 4654 1083 to 90     Submitted on the opposite strand 994/1316
(75 %)
11 diff
(99.2 %id)
FN118534 breast carcinoma .b 3662 to 3736 77 to 1     Submitted on the opposite strand 77/78
(98 %)
2 diff
(97.5 %id)
ES315390 occipital scalp hair, skin .b 3835 to 3926 1 to 92       92/92
(100 %)
1 diff
(99.0 %id)
BG284518 adenocarcinoma, cell line, Prostate .b 3892 to 4682 1 to 797       797/993
(80 %)
28 diff
(97.2 %id)
AA382641 testis .b 3895 to 4039 10 to 154       145/154
(94 %)
6 diff
(96.2 %id)
BE939503 uterus .b 3906 to 4421 15 to 530       516/543
(95 %)
10 diff
(98.2 %id)
AA382660 testis .b 3971 to 4228 1 to 258       258/266
(96 %)
0 diff
(100 %id)
TI_2016728757   .b 3974 to 4656 1 to 681       681/1292
(52 %)
5 diff
(99.7 %id)
BE706362 head_neck .b 3977 to 4282 314 to 11       304/324
(93 %)
5 diff
(98.5 %id)
BI223311 cervical carcinoma cell line, cervix .b 4010 to 4713 1 to 706       706/766
(92 %)
14 diff
(98.2 %id)
AW867746 stomach_normal .b 4021 to 4687 1 to 662       662/666
(99 %)
12 diff
(98.2 %id)
R84625 liver and spleen .b 4063 to 4347 1 to 285       285/285
(100 %)
3 diff
(99.0 %id)
BE907318 epithelioid carcinoma, Pancreas .b 4066 to 4711 1 to 642       642/873
(73 %)
18 diff
(98.0 %id)
TI_2016731103   .b 4114 to 4656 724 to 180       545/724
(75 %)
2 diff
(99.8 %id)
DB383022   .b 4163 to 4716 555 to 1       555/555
(100 %)
1 diff
(99.9 %id)
AI924554 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .b 4179 to 4710 544 to 12   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 533/533
(100 %)
2 diff
(99.7 %id)
BM928563 hepatocellular carcinoma, cell line, Liver .b 4217 to 4710 1 to 494   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 494/494
(100 %)
0 diff
(100 %id)
BQ652797 hepatocellular carcinoma, cell line, Liver .b 4217 to 4711 1 to 495       495/495
(100 %)
0 diff
(100 %id)
BQ645006 hepatocellular carcinoma, cell line, Liver .b 4217 to 4710 1 to 494   AAA   494/503
(98 %)
1 diff
(99.9 %id)
BQ645297 hepatocellular carcinoma, cell line, Liver .b 4224 to 4710 7 to 493   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 487/493
(98 %)
6 diff
(98.8 %id)
BQ649278 hepatocellular carcinoma, cell line, Liver .b 4224 to 4711 26 to 513       488/513
(95 %)
1 diff
(99.9 %id)
BG205320   .b 4225 to 4970 1 to 745   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 745/745
(100 %)
17 diff
(97.8 %id)
BG211598   .b 4226 to 4966 1 to 742   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 742/742
(100 %)
13 diff
(98.3 %id)
AA983674 pooled .b 4256 to 4711 461 to 6       456/461
(98 %)
0 diff
(100 %id)
BG203257   .b 4286 to 4711 482 to 56     Submitted on the opposite strand 427/545
(78 %)
0 diff
(100 %id)
BG211599   .b 4303 to 4916 80 to 692   AAA   613/739
(82 %)
19 diff
(97.5 %id)
BM542939 embryonal carcinoma, cell line, testis .b 4304 to 4966 1 to 663   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 663/663
(100 %)
0 diff
(100 %id)
AI133089 Liver .b 4305 to 4582 280 to 2       279/286
(97 %)
0 diff
(100 %id)
DB565250 hypothalamus .b 4305 to 4709 46 to 451     Submitted on the opposite strand 406/452
(89 %)
2 diff
(99.6 %id)
BG183078   .b 4308 to 4716 1 to 409   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 409/409
(100 %)
5 diff
(98.8 %id)
BG186788   .b 4308 to 4972 3 to 661   tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 659/661
(99 %)
6 diff
(99.1 %id)
BG193038   .b 4308 to 4966 1 to 658   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 658/658
(100 %)
4 diff
(99.4 %id)
BG200416   .b 4308 to 4478 35 to 203       169/203
(83 %)
8 diff
(96.1 %id)
BG204259   .b 4308 to 4955 1 to 640   AAA   640/651
(98 %)
17 diff
(97.4 %id)
BG208466   .b 4309 to 4711 1 to 403   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 403/405
(99 %)
11 diff
(97.3 %id)
BG209563   .b 4309 to 4715 1 to 405   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 405/405
(100 %)
3 diff
(99.3 %id)
BG220485   .b 4309 to 4710 1 to 399   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 399/399
(100 %)
11 diff
(97.3 %id)
TI_151755767   .b 4309 to 4966 749 to 92   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 658/919
(71 %)
0 diff
(100 %id)
BG195547   .b 4316 to 4631 10 to 326       317/326
(97 %)
6 diff
(98.2 %id)
TI_154133837   .b 4331 to 4966 724 to 88   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 637/1110
(57 %)
20 diff
(98.2 %id)
AW591203 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 4339 to 4714 378 to 2       377/378
(99 %)
0 diff
(100 %id)
BU622374 cell lines, Chondrosarcoma .b 4339 to 4966 646 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 628/628
(100 %)
0 diff
(100 %id)
AV698473 hepatocellular carcinoma .b 4380 to 4690 67 to 372       306/373
(82 %)
3 diff
(99.2 %id)
AI024405   .b 4389 to 4711 331 to 9       323/331
(97 %)
0 diff
(100 %id)
AA862573 pooled germ cell tumors .b 4401 to 4716 326 to 11   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 316/316
(100 %)
0 diff
(100 %id)
CA314521 Human Lung Epithelial cells, lung .b 4430 to 4966 555 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 537/546
(98 %)
0 diff
(100 %id)
GD137778   .b 4461 to 4629 176 to 8   AAA Submitted on the opposite strand 169/211
(80 %)
0 diff
(100 %id)
AW770877 colon, juvenile granulosa tumor .b 4462 to 4966 505 to 1       505/505
(100 %)
0 diff
(100 %id)
BE300684 melanotic melanoma, skin .b 4471 to 4841 371 to 1       371/371
(100 %)
0 diff
(100 %id)
AW576163 lymph .b 4471 to 4966 514 to 18   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 497/497
(100 %)
2 diff
(99.6 %id)
AW519293 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 4558 to 4966 409 to 1       409/409
(100 %)
0 diff
(100 %id)
R85383 liver and spleen .b 4590 to 4966 386 to 1       386/502
(76 %)
8 diff
(98.5 %id)
FN049090 breast carcinoma .b 4717 to 4830 114 to 1     Submitted on the opposite strand 114/115
(99 %)
1 diff
(99.2 %id)
GD137472   .b 4899 to 4970 1 to 73       73/89
(82 %)
3 diff
(96.7 %id)
DB053333 testis .c 1 to 535 2 to 537   tiling clone, capped   536/536
(100 %)
2 diff
(99.7 %id)
DB081584 testis .c 449 to 960 2 to 514   capped   513/513
(100 %)
1 diff
(99.9 %id)
AL136808 testis .c 459 to 3528 1 to 3070   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 3070/3070
(100 %)
1 diff
(100.0 %id)
CR533554   .c 529 to 3159 1 to 2631       2631/2631
(100 %)
0 diff
(100 %id)
DB084038 testis .c 547 to 1100 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
BG213692   .c 2920 to 3508 599 to 13     Submitted on the opposite strand 587/793
(74 %)
0 diff
(100 %id)
BG184085   .c 2922 to 3510 1 to 589       589/782
(75 %)
17 diff
(97.9 %id)
AL041561 testis .c 3088 to 3518 455 to 25   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 431/431
(100 %)
0 diff
(100 %id)
BG114502 Bone, osteosarcoma, cell line .c 3099 to 3528 1 to 431   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 431/431
(100 %)
1 diff
(99.8 %id)
BG209364   .c 3259 to 3510 296 to 47     Submitted on the opposite strand 250/296
(84 %)
0 diff
(100 %id)
DA864953 placenta .d 1 to 543 9 to 551   tiling clone, capped   550/550
(100 %)
0 diff
(100 %id)
DB038533 testis .d 1 to 559 9 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
DA859911 placenta .d 1 to 522 2 to 523   capped   522/522
(100 %)
0 diff
(100 %id)
AL705836 human skeletal muscle .d 95 to 830 1 to 736       736/740
(99 %)
2 diff
(99.8 %id)
DR006053 Prostate .d 121 to 823 1 to 703       703/705
(99 %)
6 diff
(99.2 %id)
DB040802 testis .d 211 to 758 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
DA834926 placenta .d 266 to 813 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
DA930206 small intestine .d 271 to 877 2 to 608   capped   607/607
(100 %)
3 diff
(99.6 %id)
CB996024 placenta, pre-eclamptic placenta .d 273 to 1019 20 to 772       753/796
(94 %)
12 diff
(98.5 %id)
CB996018 placenta, pre-eclamptic placenta .d 273 to 964 20 to 711       692/853
(81 %)
4 diff
(99.6 %id)
CB997052 placenta, pre-eclamptic placenta .d 273 to 970 20 to 720       701/799
(87 %)
19 diff
(97.7 %id)
CB995629 placenta, pre-eclamptic placenta .d 273 to 866 20 to 611       592/700
(84 %)
7 diff
(99.0 %id)
DA857110 placenta .d 274 to 830 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DB004723 breast, tumor tissue .d 275 to 855 2 to 582   capped   581/581
(100 %)
2 diff
(99.7 %id)
TI_1948136802   .d 292 to 964 128 to 801       674/1416
(47 %)
22 diff
(98.5 %id)
TI_1948136803   .d 292 to 804 115 to 627       513/1378
(37 %)
18 diff
(98.7 %id)
TI_1948137144   .d 292 to 964 125 to 799       675/1376
(49 %)
28 diff
(98.0 %id)
TI_1948137831   .d 292 to 945 123 to 780       658/1481
(44 %)
32 diff
(97.9 %id)
TI_1948137832   .d 292 to 965 121 to 797       677/1332
(50 %)
14 diff
(99.0 %id)
AF456126   .d 297 to 1877 1 to 1581 exact tiling clone,   1581/1581
(100 %)
1 diff
(100.0 %id)
CV029120 mixed .d 297 to 954 1 to 657       657/657
(100 %)
4 diff
(99.4 %id)
TI_1948137483   .d 300 to 970 130 to 800       671/1442
(46 %)
5 diff
(99.7 %id)
TI_1948137484   .d 300 to 930 132 to 763       632/1333
(47 %)
13 diff
(99.1 %id)
BX371960 Placenta Cot 25-normalized .d 402 to 1317 914 to 1       914/914
(100 %)
8 diff
(99.2 %id)
DB094965 testis .d 697 to 1292 2 to 597   capped   596/596
(100 %)
0 diff
(100 %id)
DA590667 lung .d 701 to 1250 2 to 552   capped   551/551
(100 %)
4 diff
(99.3 %id)
DA934248 Spleen .d 874 to 1467 2 to 595   capped   594/594
(100 %)
1 diff
(99.9 %id)
BE536390 cervix .d 877 to 945 569 to 637       605/638
(94 %)
23 diff
(96.4 %id)
AK000378   .d 966 to 3569 994 to 3597 V16A S439F tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 3597/3597
(100 %)
7 diff
(99.9 %id)
AY260572 Pituitary .d 966 to 2517 1026 to 2577 exact     2577/2577
(100 %)
2 diff
(100.0 %id)
AY260577 Pituitary .d 966 to 3569 1026 to 3629 exact     3629/3629
(100 %)
2 diff
(100.0 %id)
BC019087 Colon, adenocarcinoma .d 966 to 2510 1009 to 2553 exact available from MGC, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 2553/2553
(100 %)
0 diff
(100 %id)
NM_017791.2   .d 966 to 3574 1046 to 3654 exact RefSeq, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 3654/3654
(100 %)
0 diff
(100 %id)
AA305338 colon .d 1010 to 1408 1 to 399       399/399
(100 %)
1 diff
(99.8 %id)
AK027804 placenta .d 1033 to 2517 1 to 1485   available from FLJ,   1485/1485
(100 %)
2 diff
(99.9 %id)
DA830395 placenta .d 1033 to 1696 2 to 666   capped   665/665
(100 %)
9 diff
(98.7 %id)
T79253 liver and spleen .d 1077 to 1617 1 to 549       549/549
(100 %)
13 diff
(97.7 %id)
DA348218 substantia nigra .d 1123 to 1673 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
TI_1948137146   .d 1253 to 1874 750 to 130       621/1336
(46 %)
19 diff
(98.6 %id)
TI_1948137833   .d 1261 to 1876 744 to 126       619/1267
(48 %)
16 diff
(98.8 %id)
TI_1948137834   .d 1312 to 1876 709 to 131       579/1495
(38 %)
22 diff
(98.6 %id)
TI_1948137485   .d 1413 to 1876 587 to 124       464/1214
(38 %)
6 diff
(99.6 %id)
BX360231 Placenta Cot 25-normalized .d 1506 to 2483 980 to 5       976/980
(99 %)
2 diff
(99.8 %id)
BM452265 melanotic melanoma, skin .d 1506 to 2526 8 to 1033       1026/1091
(94 %)
33 diff
(97.0 %id)
BG980783 colon_normal .d 1534 to 1942 42 to 448       407/448
(90 %)
12 diff
(97.4 %id)
DC424223   .d 1720 to 2317 1 to 600       600/603
(99 %)
9 diff
(98.6 %id)
CD367972 Alveolar Macrophage, lung .d 1806 to 2517 730 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 712/712
(100 %)
1 diff
(99.9 %id)
CD366409 Alveolar Macrophage, lung .d 1812 to 2517 722 to 17   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 706/706
(100 %)
0 diff
(100 %id)
TI_151706949   .d 1821 to 2221 454 to 54       401/1062
(37 %)
0 diff
(100 %id)
BM694777 eye, RPE and Choroid .d 1825 to 2215 1 to 391       391/395
(98 %)
1 diff
(99.8 %id)
DN912135   .d 1899 to 2472 1 to 574       574/574
(100 %)
0 diff
(100 %id)
CD370723 Alveolar Macrophage, lung .d 1906 to 2510 621 to 17   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 605/617
(98 %)
0 diff
(100 %id)
AW001026 Kidney .d 1955 to 2517 564 to 1       564/564
(100 %)
2 diff
(99.7 %id)
AA614057   .d 1960 to 2514 561 to 8       554/561
(98 %)
0 diff
(100 %id)
AA614050   .d 1960 to 2514 563 to 8       556/563
(98 %)
0 diff
(100 %id)
BF194917 Kidney .d 1966 to 2516 555 to 5       551/555
(99 %)
0 diff
(100 %id)
AI694037 carcinoid, lung .d 1978 to 2517 543 to 4       540/543
(99 %)
0 diff
(100 %id)
AA978366 2 pooled tumors (clear cell type), Kidney .d 1979 to 2514 536 to 1       536/536
(100 %)
0 diff
(100 %id)
AI697799 carcinoid, lung .d 1980 to 2517 541 to 4       538/541
(99 %)
0 diff
(100 %id)
BE467885 carcinoid, lung .d 1984 to 2517 537 to 4       534/537
(99 %)
0 diff
(100 %id)
BM674334 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 2001 to 2517 535 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 517/537
(96 %)
0 diff
(100 %id)
AI681905 carcinoid, lung .d 2037 to 2517 484 to 4       481/484
(99 %)
0 diff
(100 %id)
DB375547 placenta .d 2037 to 2517 481 to 1       481/483
(99 %)
1 diff
(99.8 %id)
T79170 liver and spleen .d 2042 to 2517 482 to 7       476/482
(98 %)
0 diff
(100 %id)
BE467846 carcinoid, lung .d 2044 to 2517 477 to 4       474/477
(99 %)
0 diff
(100 %id)
BE549746 carcinoid, lung .d 2046 to 2517 475 to 4       472/475
(99 %)
0 diff
(100 %id)
R71180 placenta .d 2048 to 2469 1 to 433       433/433
(100 %)
11 diff
(97.5 %id)
DB521590 testis .d 2053 to 2517 1 to 466     Submitted on the opposite strand 466/466
(100 %)
4 diff
(99.2 %id)
AI478149 Kidney .d 2058 to 2536 479 to 1       479/479
(100 %)
2 diff
(99.6 %id)
AA705305 liver and spleen .d 2066 to 2517 453 to 1       453/453
(100 %)
4 diff
(99.2 %id)
AA621018   .d 2067 to 2515 459 to 11   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 449/449
(100 %)
1 diff
(99.8 %id)
AI300825 2 pooled tumors (clear cell type), Kidney .d 2072 to 2514 443 to 1       443/443
(100 %)
0 diff
(100 %id)
AW293106   .d 2076 to 2517 457 to 16   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 442/442
(100 %)
1 diff
(99.8 %id)
AI130016 uterus .d 2085 to 2512 428 to 1       428/428
(100 %)
1 diff
(99.8 %id)
AI560194 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 2150 to 2515 383 to 18       366/383
(95 %)
0 diff
(100 %id)
AI873386 pooled .d 2177 to 2516 342 to 4       339/344
(98 %)
0 diff
(100 %id)
BF590406 Kidney .d 2183 to 2517 338 to 1       338/338
(100 %)
4 diff
(98.9 %id)
AW271500 Kidney .d 2191 to 2517 327 to 1       327/327
(100 %)
0 diff
(100 %id)
BQ029814 lung, Metastatic Chondrosarcoma .d 2215 to 2515 314 to 14   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 301/301
(100 %)
1 diff
(99.7 %id)
R94883 liver and spleen .d 2268 to 2694 1 to 435       435/467
(93 %)
18 diff
(96.2 %id)
R71114 placenta .d 2311 to 2835 1 to 528       528/528
(100 %)
6 diff
(98.9 %id)
BX452066 brain, fetal brain .d 2329 to 3276 1 to 941       941/970
(97 %)
28 diff
(97.2 %id)
N78013 liver and spleen .d 2416 to 2994 1 to 596       596/597
(99 %)
26 diff
(95.7 %id)
H61929 liver and spleen .d 2418 to 2810 1 to 397       397/397
(100 %)
12 diff
(97.0 %id)
BG258518 embryonal carcinoma, cell line, testis .d 2500 to 3312 1 to 805       805/943
(85 %)
19 diff
(98.0 %id)
BX110402 liver and spleen .d 2575 to 3252 1 to 678       678/680
(99 %)
2 diff
(99.8 %id)
R17999.
matches multiple genes
liver and spleen .d 2576 to 2909 1 to 339     also hits gene mynabu 339/348
(97 %)
8 diff
(97.8 %id)
W35200 heart .d 2576 to 3026 1 to 457       457/457
(100 %)
7 diff
(98.5 %id)
H94906 liver and spleen .d 2771 to 3168 1 to 405   fully sequenced,   405/405
(100 %)
4 diff
(99.1 %id)
BM723884 eye, fetal eye .d 2775 to 3193 1 to 418   fully sequenced, Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 418/418
(100 %)
0 diff
(100 %id)
BX456262 brain, fetal brain .d 2811 to 3541 1 to 730       730/730
(100 %)
1 diff
(99.9 %id)
CA307014 Alveolar Macrophage, lung .d 2827 to 3569 759 to 17   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 743/743
(100 %)
4 diff
(99.5 %id)
CA748534 Alveolar Macrophage, lung .d 2863 to 3569 721 to 17   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 705/705
(100 %)
3 diff
(99.6 %id)
BQ008063 Chondrosarcoma, Left Pelvis .d 2910 to 3569 676 to 17   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 660/660
(100 %)
0 diff
(100 %id)
BQ773683 Chondrosarcoma Grade II, Left Pelvis .d 2912 to 3569 672 to 17   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 656/656
(100 %)
3 diff
(99.6 %id)
AA393165   .d 2956 to 3175 1 to 219   fully sequenced, Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 219/219
(100 %)
1 diff
(99.6 %id)
AI637633 pooled germ cell tumors .d 2965 to 3569 616 to 13   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 604/604
(100 %)
1 diff
(99.9 %id)
TI_153989232   .d 2973 to 3572 683 to 88       596/720
(82 %)
0 diff
(100 %id)
N78018 liver and spleen .d 2974 to 3565 1 to 593   fully sequenced, AAA   593/593
(100 %)
13 diff
(97.9 %id)
CR739521 liver and spleen .d 2975 to 3574 1 to 600   tiling clone, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 600/600
(100 %)
0 diff
(100 %id)
H73384 liver and spleen .d 2976 to 3384 1 to 420   fully sequenced,   420/420
(100 %)
7 diff
(98.4 %id)
BU627408 Bone, Enchondroma cell line .d 2994 to 3569 594 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 576/576
(100 %)
0 diff
(100 %id)
AI948573 2 pooled tumors (clear cell type), Kidney .d 2995 to 3572 578 to 1       578/578
(100 %)
2 diff
(99.7 %id)
CA308735 Alveolar Macrophage, lung .d 2995 to 3569 593 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 575/575
(100 %)
1 diff
(99.9 %id)
DN912136   .d 3020 to 3565 548 to 3       546/548
(99 %)
0 diff
(100 %id)
AI637607 pooled germ cell tumors .d 3029 to 3570 541 to 1       541/541
(100 %)
1 diff
(99.9 %id)
BE552379 pooled germ cell tumors .d 3029 to 3572 545 to 2       544/545
(99 %)
0 diff
(100 %id)
AI948579 2 pooled tumors (clear cell type), Kidney .d 3040 to 3572 533 to 1       533/533
(100 %)
2 diff
(99.7 %id)
AW237074 pooled germ cell tumors .d 3044 to 3571 528 to 1       528/528
(100 %)
0 diff
(100 %id)
BF060693 pooled .d 3044 to 3569 538 to 13   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 526/526
(100 %)
0 diff
(100 %id)
AI656925 pooled germ cell tumors .d 3045 to 3569 525 to 1       525/525
(100 %)
2 diff
(99.7 %id)
AW515719 pooled germ cell tumors .d 3046 to 3569 525 to 1       525/525
(100 %)
4 diff
(99.3 %id)
AI655689 pooled germ cell tumors .d 3088 to 3569 503 to 22   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 482/482
(100 %)
2 diff
(99.6 %id)
AW235884 pooled germ cell tumors .d 3102 to 3569 468 to 1       468/468
(100 %)
0 diff
(100 %id)
AW167543 cervix .d 3111 to 3572 475 to 14       462/475
(97 %)
0 diff
(100 %id)
AA628874   .d 3123 to 3572 452 to 2       451/452
(99 %)
0 diff
(100 %id)
DB515120 testis .d 3128 to 3567 1 to 438     Submitted on the opposite strand 438/438
(100 %)
6 diff
(98.7 %id)
H94848 liver and spleen .d 3138 to 3570 437 to 1   fully sequenced,   437/437
(100 %)
9 diff
(98.0 %id)
H61723 liver and spleen .d 3144 to 3566 435 to 1       435/447
(97 %)
24 diff
(94.7 %id)
DB514369 testis .d 3145 to 3569 1 to 426     Submitted on the opposite strand 426/426
(100 %)
4 diff
(99.1 %id)
AA398561   .d 3145 to 3569 447 to 22   fully sequenced, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 426/426
(100 %)
1 diff
(99.8 %id)
AI094422 pooled .d 3149 to 3566 417 to 1       417/417
(100 %)
3 diff
(99.3 %id)
BM680050 eye, fetal eye .d 3163 to 3569 423 to 17   fully sequenced, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 407/407
(100 %)
0 diff
(100 %id)
AA682445 liver and spleen .d 3164 to 3569 420 to 14   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 407/407
(100 %)
4 diff
(99.1 %id)
BE464472 pooled germ cell tumors .d 3185 to 3569 385 to 1       385/385
(100 %)
1 diff
(99.8 %id)
AW002908 pooled germ cell tumors .d 3189 to 3571 383 to 1       383/383
(100 %)
1 diff
(99.8 %id)
AW340784 2 pooled tumors (clear cell type), Kidney .d 3209 to 3572 364 to 1       364/364
(100 %)
1 diff
(99.8 %id)
AW205359   .d 3210 to 3572 376 to 15       362/376
(96 %)
0 diff
(100 %id)
AA628873   .d 3239 to 3572 335 to 2       334/335
(99 %)
0 diff
(100 %id)
R71181 placenta .d 3257 to 3567 315 to 1       315/464
(67 %)
7 diff
(98.5 %id)
R17907 liver and spleen .d 3268 to 3572 305 to 1       305/305
(100 %)
4 diff
(98.7 %id)
AA705116 liver and spleen .d 3287 to 3569 283 to 1       283/283
(100 %)
0 diff
(100 %id)
N58423 liver and spleen .d 3289 to 3569 283 to 1       283/283
(100 %)
2 diff
(99.3 %id)
BM145610 leukopheresis .d 3333 to 3572 251 to 12       240/251
(95 %)
0 diff
(100 %id)
H73385 liver and spleen .d 3354 to 3555 205 to 1   fully sequenced,   205/205
(100 %)
3 diff
(98.6 %id)
N58428 liver and spleen .d 3365 to 3574 210 to 1   fully sequenced,   210/210
(100 %)
0 diff
(100 %id)
W23756 heart .d 3379 to 3569 191 to 1       191/191
(100 %)
0 diff
(100 %id)
H58191 liver and spleen .d 3437 to 3571 136 to 2       135/145
(93 %)
0 diff
(100 %id)
DB090681 testis .e 1 to 565 2 to 566   tiling clone, capped   565/565
(100 %)
0 diff
(100 %id)
DB063784 testis .e 11 to 546 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
DB293191   .e 405 to 1173 2 to 770   tiling clone, capped   769/769
(100 %)
3 diff
(99.7 %id)
DB067340 testis .e 1161 to 1525 2 to 367   tiling clone, capped   366/366
(100 %)
1 diff
(99.8 %id)
AL133586 testis .f 1 to 1634 1 to 1634 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1634/1634
(100 %)
1 diff
(100.0 %id)
AK297002 cord Blood .g 1 to 1221 1 to 1221 exact tiling clone,   1221/1221
(100 %)
0 diff
(100 %id)
DC296806 cord Blood .g 1 to 817 1 to 812       812/812
(100 %)
9 diff
(98.9 %id)
DC296754 cord Blood .g 84 to 661 1 to 578       578/578
(100 %)
0 diff
(100 %id)
AL518276 brain, neuroblastoma, neuroblastoma cells .h 1 to 580 1 to 578   tiling clone, fully sequenced,   578/578
(100 %)
2 diff
(99.7 %id)
BC002766 Uterus, endometrium adenocarcinoma .h 3 to 1597 1 to 1595 E203D V224M tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 1595/1595
(100 %)
2 diff
(99.9 %id)
TI_1948102279   .h 208 to 1025 126 to 942 E203D V224M Y233L D234* fully sequenced,   817/942
(86 %)
19 diff
(98.0 %id)
TI_1948102446   .h 208 to 488 126 to 406   fully sequenced,   281/308
(91 %)
6 diff
(98.1 %id)
TI_1948102619   .h 208 to 1025 120 to 941 E203D V224M N255K T256Y M257H ... fully sequenced,   822/941
(87 %)
18 diff
(98.1 %id)
TI_1948102778   .h 208 to 465 126 to 383       258/285
(90 %)
5 diff
(98.3 %id)
AK024259   .h 275 to 4270 1 to 4004   tiling clone, available from FLJ,   4004/4004
(100 %)
5 diff
(99.9 %id)
AU131383   .h 276 to 1114 2 to 832   capped   831/831
(100 %)
15 diff
(98.2 %id)
BQ014896 Chondrosarcoma, Left Pubic Bone .h 334 to 1045 730 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 712/712
(100 %)
4 diff
(99.5 %id)
TI_1948102447   .h 441 to 1025 700 to 116   fully sequenced,   585/700
(83 %)
7 diff
(99.0 %id)
TI_1948102620   .h 548 to 1025 592 to 115   fully sequenced,   478/592
(80 %)
7 diff
(98.9 %id)
AL518275 brain, neuroblastoma, neuroblastoma cells .h 576 to 1552 979 to 1   fully sequenced,   979/979
(100 %)
35 diff
(96.5 %id)
TI_1948102280   .h 679 to 1025 457 to 111   fully sequenced,   347/457
(75 %)
7 diff
(98.5 %id)
TI_1948102779   .h 717 to 1025 421 to 113       309/327
(94 %)
7 diff
(97.9 %id)
AA457355   .h 2970 to 3445 1 to 473   tiling clone,   473/473
(100 %)
3 diff
(99.4 %id)
AU153123   .h 3735 to 4270 534 to 1       534/534
(100 %)
20 diff
(96.3 %id)
AA457260   .h 3823 to 4271 448 to 1   tiling clone,   448/448
(100 %)
1 diff
(99.8 %id)
BQ883922 eye, normal pigmented retinal epithelium .i 1 to 793 23 to 818 H4I K5R T6P S7H M8E ... tiling clone,   796/891
(89 %)
31 diff
(96.6 %id)
BM559747 brain, medulla .j 1 to 938 21 to 969 E241G tiling clone,   949/1060
(89 %)
31 diff
(97.1 %id)
CX761131 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .k 1 to 700 1 to 707 Q226P tiling clone, Submitted on the opposite strand 701/707
(99 %)
5 diff
(99.3 %id)
BX099711 placenta .l 1 to 806 1 to 806 exact tiling clone,   806/806
(100 %)
3 diff
(99.7 %id)
R35550 placenta .l 1 to 290 1 to 298       298/298
(100 %)
12 diff
(96.0 %id)
BM541768 leiomyosarcoma, uterus .l 20 to 931 38 to 957   tiling clone,   920/1201
(76 %)
32 diff
(97.4 %id)
R34225 placenta .l 1029 to 1386 369 to 1   tiling clone,   369/369
(100 %)
10 diff
(97.3 %id)
BC010436 Uterus, endometrium adenocarcinoma .m 2 to 817 1 to 816 D94N tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 816/816
(100 %)
1 diff
(99.9 %id)
CV028111 mixed .m 7 to 594 1 to 588       588/588
(100 %)
1 diff
(99.9 %id)
TI_1948084018   .m 7 to 647 129 to 770       642/1153
(55 %)
32 diff
(97.3 %id)
BE515088 endometrium, adenocarcinoma cell line, uterus .m 21 to 604 1 to 605       570/607
(93 %)
19 diff
(96.9 %id)
BE388662 endometrium, adenocarcinoma cell line, uterus .m 21 to 696 1 to 666       666/666
(100 %)
11 diff
(98.4 %id)
NM_052873.2   .m 61 to 820 89 to 848 exact RefSeq, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 848/848
(100 %)
0 diff
(100 %id)
TI_1948084568   .m 216 to 647 559 to 127       433/1146
(37 %)
9 diff
(99.3 %id)
DB463869 hippocampus .n -10 to 396 1 to 406       406/406
(100 %)
1 diff
(99.8 %id)
DB497730 hypothalamus .n -10 to 473 1 to 484       484/484
(100 %)
0 diff
(100 %id)
DC403738 testis .n -10 to 538 1 to 549       549/549
(100 %)
2 diff
(99.7 %id)
DN994544 brain, whole brain .n 1 to 599 8 to 606   tiling clone,   606/606
(100 %)
5 diff
(99.2 %id)
DN998288 breast cancer, Mammary gland (cancer tissue) .n 1 to 524 7 to 531       531/531
(100 %)
6 diff
(98.9 %id)
TI_57174560   .n 1 to 796 38 to 831 A20P K21R M22W G23V R24A ... tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 801/831
(96 %)
12 diff
(98.6 %id)
BG763614 melanotic melanoma, high MDR (cell line), skin .n 1 to 806 5 to 815 E111D E112R D113R F114L V115C ...     815/868
(93 %)
8 diff
(99.1 %id)
TI_159682373   .n 1 to 800 882 to 82 E2R D3I L4A L5R D6L ... AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 798/968
(82 %)
5 diff
(99.5 %id)
BQ366776 placenta_normal .n 1 to 514 530 to 16       514/530
(96 %)
3 diff
(99.5 %id)
BX102200 senescent fibroblast .n 2 to 497 1 to 498       498/498
(100 %)
3 diff
(99.4 %id)
AA044197 uterus .n 2 to 544 1 to 542   fully sequenced,   542/542
(100 %)
3 diff
(99.5 %id)
BI826698 brain, medulla .n 2 to 796 1 to 793 A20P K21R M22W G23V R24A ... AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 793/793
(100 %)
5 diff
(99.4 %id)
BF361086 ovary .n 6 to 399 394 to 1       394/402
(98 %)
7 diff
(98.3 %id)
DR423699 eye, Pterygium .n 6 to 796 1 to 791 E2R E10D L11F     791/791
(100 %)
7 diff
(99.2 %id)
BM263538 Pancreas, Purified pancreatic islet .n 10 to 627 10 to 627       618/627
(98 %)
2 diff
(99.7 %id)
CB853974 lung, Primary Lung Epithelial Cells .n 12 to 673 1 to 662     Submitted on the opposite strand 662/662
(100 %)
7 diff
(99.0 %id)
CB851407 lung, Primary Lung Epithelial Cells .n 12 to 578 1 to 567     Submitted on the opposite strand 567/567
(100 %)
8 diff
(98.6 %id)
CB851159 lung, Primary Lung Epithelial Cells .n 12 to 763 1 to 752     Submitted on the opposite strand 752/752
(100 %)
7 diff
(99.1 %id)
BG119154 adenocarcinoma, cell line, Liver .n 15 to 711 1 to 690       690/935
(73 %)
11 diff
(98.9 %id)
CB157761 Liver .n 15 to 500 1 to 485       485/485
(100 %)
3 diff
(99.4 %id)
CD671756 eye, Iris .n 16 to 582 1 to 567   fully sequenced,   567/567
(100 %)
0 diff
(100 %id)
AA442503   .n 18 to 408 1 to 391   fully sequenced,   391/391
(100 %)
1 diff
(99.8 %id)
TI_149275894   .n 18 to 794 58 to 835     Submitted on the opposite strand 778/1092
(71 %)
16 diff
(98.6 %id)
TI_149305233   .n 18 to 798 58 to 837     Submitted on the opposite strand 780/841
(92 %)
11 diff
(98.7 %id)
TI_149307425   .n 18 to 804 58 to 844     Submitted on the opposite strand 787/1071
(73 %)
31 diff
(97.2 %id)
AI807590 carcinoid, lung .n 22 to 496 1 to 475     Submitted on the opposite strand 475/475
(100 %)
3 diff
(99.4 %id)
BE789707 large cell carcinoma, lung .n 22 to 686 1 to 651       651/862
(75 %)
20 diff
(97.7 %id)
TI_151765165   .n 29 to 693 96 to 764       669/815
(82 %)
45 diff
(94.5 %id)
AI197863 anaplastic oligodendroglioma, brain .n 33 to 513 1 to 481     Submitted on the opposite strand 481/485
(99 %)
5 diff
(99.0 %id)
AA878192 carcinoid, lung .n 43 to 408 1 to 365     Submitted on the opposite strand 365/365
(100 %)
1 diff
(99.8 %id)
BF110981 carcinoid, lung .n 45 to 507 1 to 463     Submitted on the opposite strand 463/463
(100 %)
7 diff
(98.5 %id)
CD707769 normal nasopharynx .n 61 to 601 91 to 630       614/630
(97 %)
8 diff
(98.8 %id)
DB443802 testis .n 61 to 417 89 to 444       444/444
(100 %)
1 diff
(99.8 %id)
DB448564 testis .n 61 to 406 78 to 423       423/423
(100 %)
2 diff
(99.6 %id)
DB449893 testis .n 61 to 428 83 to 452       452/452
(100 %)
16 diff
(96.5 %id)
DB451514.
matches multiple genes
testis .n 61 to 472 79 to 490     also hits gene zupoyby 490/490
(100 %)
0 diff
(100 %id)
BG715464 brain, hypothalamus .n 61 to 780 80 to 795 exact     795/798
(99 %)
10 diff
(98.8 %id)
BI667167 brain, hypothalamus .n 61 to 762 80 to 781 exact     781/781
(100 %)
8 diff
(99.0 %id)
TI_44342850   .n 61 to 762 204 to 905 exact     786/905
(86 %)
10 diff
(98.9 %id)
NM_001102564.1   .n 61 to 805 89 to 833 exact RefSeq, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 833/833
(100 %)
0 diff
(100 %id)
TI_149302857   .n 61 to 797 820 to 85   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 736/960
(76 %)
2 diff
(99.8 %id)
BU629473 cell lines, Chondrosarcoma .n 63 to 797 751 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 733/734
(99 %)
2 diff
(99.8 %id)
CB850999 lung, Primary Lung Cystic Fibrosis EpithelialCells .n 92 to 797 723 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 705/705
(100 %)
2 diff
(99.8 %id)
BQ025134 placenta .n 123 to 796 691 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 673/673
(100 %)
2 diff
(99.8 %id)
BF733027 fibrotheoma, ovary .n 154 to 798 653 to 9       645/653
(98 %)
4 diff
(99.4 %id)
CA312058 Human Lung Epithelial cells, lung .n 165 to 796 650 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 632/632
(100 %)
1 diff
(99.9 %id)
BU730210 eye, Retina Foveal and Macular .n 191 to 796 624 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 606/606
(100 %)
0 diff
(100 %id)
AA057294 uterus .n 201 to 481 1 to 282   fully sequenced,   282/282
(100 %)
1 diff
(99.7 %id)
BM263253 Pancreas, Purified pancreatic islet .n 216 to 802 589 to 1       589/597
(98 %)
8 diff
(98.7 %id)
CK824512 Pancreas, Purified pancreatic islet .n 222 to 802 590 to 10     Submitted on the opposite strand 581/591
(98 %)
0 diff
(100 %id)
AW510650 pooled .n 278 to 800 525 to 3       523/525
(99 %)
0 diff
(100 %id)
BM987472 mixed .n 285 to 749 483 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 465/465
(100 %)
0 diff
(100 %id)
AI863892 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .n 286 to 751 466 to 1       466/466
(100 %)
0 diff
(100 %id)
AW827281 hepatic adenoma, Liver .n 315 to 797 12 to 494       483/494
(97 %)
6 diff
(98.8 %id)
AI128020 uterus .n 319 to 753 440 to 6       435/440
(98 %)
0 diff
(100 %id)
AI341875 pooled germ cell tumors .n 323 to 802 480 to 1       480/480
(100 %)
0 diff
(100 %id)
CN368324 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .n 327 to 802 8 to 483   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 476/483
(98 %)
6 diff
(98.8 %id)
AI693935 pooled .n 328 to 805 479 to 2       478/479
(99 %)
0 diff
(100 %id)
AW084180 esophagus, squamous cell carcinoma .n 328 to 797 470 to 1       470/470
(100 %)
0 diff
(100 %id)
AI478873 pooled .n 330 to 798 475 to 7       469/475
(98 %)
0 diff
(100 %id)
DB568828 hypothalamus .n 331 to 802 1 to 472     Submitted on the opposite strand 472/472
(100 %)
0 diff
(100 %id)
DB508775 testis .n 332 to 755 1 to 424     Submitted on the opposite strand 424/424
(100 %)
0 diff
(100 %id)
AI361030 brain, glioblastoma (pooled) .n 334 to 755 433 to 12   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 422/422
(100 %)
1 diff
(99.8 %id)
AW270076 pooled .n 339 to 798 463 to 4       460/463
(99 %)
0 diff
(100 %id)
AA569515   .n 353 to 734 1 to 383       383/383
(100 %)
5 diff
(98.7 %id)
AI125985 uterus .n 353 to 753 406 to 6       401/406
(98 %)
0 diff
(100 %id)
DB515202 testis .n 359 to 797 1 to 439     Submitted on the opposite strand 439/439
(100 %)
0 diff
(100 %id)
W47168 senescent fibroblast .n 359 to 802 449 to 6       444/449
(98 %)
3 diff
(99.4 %id)
AI866841 adenocarcinoma, Pancreas .n 360 to 752 393 to 1       393/393
(100 %)
1 diff
(99.8 %id)
DB513677 testis .n 362 to 749 1 to 391     Submitted on the opposite strand 389/393
(98 %)
7 diff
(98.3 %id)
DB529936 hippocampus .n 362 to 797 1 to 434     Submitted on the opposite strand 434/434
(100 %)
5 diff
(98.9 %id)
AI377480   .n 362 to 796 443 to 9       435/443
(98 %)
0 diff
(100 %id)
AI126860 heart .n 363 to 796 435 to 2       434/435
(99 %)
0 diff
(100 %id)
AA954427 pooled .n 365 to 805 441 to 1       441/441
(100 %)
4 diff
(99.1 %id)
AI248057 liver and spleen .n 372 to 751 380 to 1       380/385
(98 %)
3 diff
(99.3 %id)
BM924103 pooled colon, kidney, stomach .n 376 to 802 11 to 437   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 427/437
(97 %)
6 diff
(98.7 %id)
N78986 lung .n 377 to 796 419 to 1       419/420
(99 %)
7 diff
(98.4 %id)
AA436700   .n 378 to 796 423 to 6   fully sequenced,   418/423
(98 %)
0 diff
(100 %id)
DB510258 testis .n 386 to 797 1 to 417     Submitted on the opposite strand 417/417
(100 %)
8 diff
(98.1 %id)
AI371151   .n 386 to 800 436 to 22   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 415/415
(100 %)
0 diff
(100 %id)
BE742565 adenocarcinoma cell line, ovary .n 387 to 796 1 to 410       410/410
(100 %)
0 diff
(100 %id)
AA977682 carcinoid, lung .n 392 to 802 413 to 4       410/413
(99 %)
2 diff
(99.6 %id)
EL952095 eyeball .n 394 to 803 45 to 453   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 409/453
(90 %)
6 diff
(98.7 %id)
CB051990 leiomyosarcoma, soft tissue .n 404 to 802 424 to 25   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 400/409
(97 %)
7 diff
(98.3 %id)
AW874553 tumor, uterus .n 406 to 797 412 to 21   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 392/392
(100 %)
5 diff
(98.8 %id)
AA741343 2 pooled tumors (clear cell type), Kidney .n 407 to 745 338 to 1       338/338
(100 %)
6 diff
(98.3 %id)
AA058739 uterus .n 420 to 803 384 to 1   fully sequenced,   384/384
(100 %)
6 diff
(98.5 %id)
AI015238   .n 438 to 745 308 to 1       308/308
(100 %)
2 diff
(99.4 %id)
BG897353 cartilage .n 440 to 802 63 to 425       363/432
(84 %)
1 diff
(99.8 %id)
AI241415 liver and spleen .n 465 to 796 337 to 7       331/338
(97 %)
1 diff
(99.8 %id)
AA044022 uterus .n 483 to 797 315 to 1   fully sequenced,   315/315
(100 %)
6 diff
(98.1 %id)
AI817614 normal prostate, Prostate .n 483 to 801 328 to 9       320/328
(97 %)
0 diff
(100 %id)
AI253728 Prostate .n 507 to 751 245 to 1       245/245
(100 %)
0 diff
(100 %id)
AA741566 germinal center B cell .n 515 to 797 293 to 12   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 282/282
(100 %)
1 diff
(99.7 %id)
AW075241 anaplastic oligodendroglioma, brain .n 555 to 797 246 to 1       246/246
(100 %)
3 diff
(98.8 %id)
AA954562 pooled .n 562 to 805 244 to 1   tiling clone,   244/244
(100 %)
0 diff
(100 %id)
CD671755 eye, Iris .n 564 to 806 277 to 35   fully sequenced,   243/277
(87 %)
0 diff
(100 %id)
AI091720 pooled .n 569 to 751 183 to 1       183/183
(100 %)
0 diff
(100 %id)
AI873353 pooled .n 578 to 798 223 to 3       221/223
(99 %)
0 diff
(100 %id)
AA661798 alveolar rhabdomyosarcoma .n 616 to 798 187 to 5       183/187
(97 %)
0 diff
(100 %id)
AI124978 aorta .n 630 to 795 170 to 5       166/170
(97 %)
0 diff
(100 %id)
AW439039 serous papillary carcinoma, high grade, 2pooled tumors, uterus .n 652 to 805 171 to 18   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 154/154
(100 %)
1 diff
(99.4 %id)
FN147455 breast carcinoma .n 689 to 787 1 to 98       98/98
(100 %)
8 diff
(91.9 %id)
FN107913 breast carcinoma .n 706 to 795 1 to 92       92/94
(97 %)
9 diff
(90.5 %id)
FN082280 breast carcinoma .n 714 to 795 1 to 81       81/91
(89 %)
2 diff
(97.9 %id)
FN123624 breast carcinoma .n 734 to 803 1 to 70       70/71
(98 %)
1 diff
(98.6 %id)
AK302944 testis .o -10 to 1003 1 to 1014 Y13C D134Y tiling clone,   1014/1014
(100 %)
2 diff
(99.9 %id)
T19288   .o 1 to 153 5 to 157   tiling clone,   157/172
(91 %)
4 diff
(97.7 %id)
CD710366 normal nasopharynx .o 3 to 323 32 to 352       321/352
(91 %)
8 diff
(97.8 %id)
FN160182 breast carcinoma .o 12 to 109 98 to 1     Submitted on the opposite strand 98/98
(100 %)
1 diff
(99.0 %id)
T49367 placenta .o 25 to 353 1 to 328       328/329
(99 %)
9 diff
(97.3 %id)
C04039 heart .o 30 to 364 1 to 335       335/335
(100 %)
3 diff
(99.2 %id)
AA935929 carcinoid, lung .o 42 to 128 1 to 87     Submitted on the opposite strand 87/87
(100 %)
0 diff
(100 %id)
CK824511 Pancreas, Purified pancreatic islet .o 43 to 375 1 to 340     Submitted on the opposite strand 340/357
(95 %)
12 diff
(96.7 %id)
BM749645 stomach .o 66 to 576 1 to 511   tiling clone,   511/511
(100 %)
0 diff
(100 %id)
CD710660 normal nasopharynx .o 72 to 485 1 to 416       416/416
(100 %)
1 diff
(99.8 %id)
AA385418 thyroid gland .o 78 to 466 1 to 393       393/395
(99 %)
6 diff
(98.5 %id)
BE774317 uterus .o 372 to 600 245 to 17       229/245
(93 %)
1 diff
(99.6 %id)
BF572117 melanotic melanoma, high MDR, skin .p 1 to 628 1 to 640   tiling clone,   635/843
(75 %)
45 diff
(94.7 %id)
BF977045 melanotic melanoma, high MDR, skin .p 1 to 553 1 to 550   tiling clone,   550/871
(63 %)
10 diff
(98.9 %id)
BE961011 melanotic melanoma, high MDR, skin .p 22 to 545 1 to 524   tiling clone,   524/605
(86 %)
15 diff
(97.6 %id)
AW119209 pooled .p 532 to 1000 471 to 3   tiling clone,   469/471
(99 %)
0 diff
(100 %id)
W16488 lung .q 1 to 424 1 to 419   tiling clone,   419/419
(100 %)
13 diff
(96.9 %id)
BF528240 anaplastic oligodendroglioma with 1p/19qloss, brain .q 269 to 1039 37 to 794 W153G D154T W155G D156T H157I ... tiling clone,   758/910
(83 %)
35 diff
(96.2 %id)
N90928 lung .q 587 to 1082 489 to 1   tiling clone,   489/507
(96 %)
9 diff
(98.3 %id)
CD000103 Pooled-Skin .r 1 to 533 1 to 541 R19L F142L F143L M144Y T145D ... tiling clone,   541/832
(65 %)
19 diff
(97.8 %id)
BY798137 eye .s 1 to 527 1 to 527   tiling clone,   527/527
(100 %)
1 diff
(99.9 %id)
W25217 senescent fibroblast .s 1 to 294 1 to 298       296/309
(95 %)
8 diff
(97.5 %id)
BQ215457 large cell carcinoma, lung .s 1 to 828 1 to 829 E8G tiling clone,   829/829
(100 %)
4 diff
(99.6 %id)
R25984 placenta .s 422 to 702 1 to 287       287/287
(100 %)
7 diff
(97.6 %id)
AI193172 lung .s 488 to 956 470 to 4       467/470
(99 %)
0 diff
(100 %id)
AI423508 brain, glioblastoma (pooled) .s 498 to 960 463 to 1       463/463
(100 %)
3 diff
(99.4 %id)
N99867 senescent fibroblast .s 513 to 960 445 to 8       438/461
(95 %)
0 diff
(100 %id)
AI279014 carcinoid, lung .s 528 to 965 446 to 9   tiling clone,   438/446
(98 %)
0 diff
(100 %id)
AI034248 parathyroid gland, parathyroid tumor .s 532 to 955 437 to 14   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 424/424
(100 %)
1 diff
(99.8 %id)
AI193173 lung .s 532 to 956 426 to 3       424/426
(99 %)
0 diff
(100 %id)
AI709240 aorta .s 559 to 953 398 to 4       395/398
(99 %)
0 diff
(100 %id)
AW129527 serous papillary carcinoma, high grade, 2pooled tumors, uterus .s 560 to 954 422 to 28   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 395/395
(100 %)
3 diff
(99.3 %id)
AI097448 brain, glioblastoma (pooled) .s 571 to 960 391 to 2       390/391
(99 %)
0 diff
(100 %id)
AA994800 breast .s 601 to 959 359 to 1       359/359
(100 %)
3 diff
(99.2 %id)
BE828846 lung_tumor .t 1 to 426 17 to 443   tiling clone,   427/446
(95 %)
15 diff
(96.7 %id)
BE828742 lung_tumor .t 40 to 476 19 to 455       437/455
(96 %)
7 diff
(98.5 %id)
BE770096 prostate_tumor .t 41 to 392 1 to 355   tiling clone,   355/355
(100 %)
10 diff
(97.2 %id)
BE828851 lung_tumor .t 144 to 476 350 to 18       333/350
(95 %)
0 diff
(100 %id)
BE828788 lung_tumor .t 148 to 476 341 to 13       329/341
(96 %)
0 diff
(100 %id)
DW418489 Liver .t 155 to 569 12 to 425   tiling clone,   414/425
(97 %)
11 diff
(97.5 %id)
DA775970 brain .u 1 to 566 2 to 567   tiling clone, capped   566/566
(100 %)
0 diff
(100 %id)
BX340136 Placenta Cot 25-normalized .u 462 to 1512 1049 to 1   tiling clone,   1049/1049
(100 %)
7 diff
(99.4 %id)
CN368322 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .va 1 to 659 1 to 660 G157R L158S S159L A160S tiling clone,   660/660
(100 %)
5 diff
(99.3 %id)
AA429105   .vb 1 to 465 1 to 464 V42F G115E G116A W117G A118Q ... tiling clone,   464/464
(100 %)
2 diff
(99.6 %id)
BF726427 eye, lens .vc 1 to 639 1 to 639 exact tiling clone,   639/639
(100 %)
0 diff
(100 %id)
BE786301 large cell carcinoma, lung .vc 27 to 625 1 to 597       597/597
(100 %)
4 diff
(99.4 %id)
BI491126 cochlea, ear .vd 1 to 518 546 to 30 S68F tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 517/524
(98 %)
3 diff
(99.5 %id)
AW020097.
matches multiple genes
cochlea, ear .vd 1 to 503 8 to 510 exact tiling clone, Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base), also hits gene CHMP2A 503/510
(98 %)
6 diff
(98.9 %id)
DB341978 testis .ve 1 to 531 1 to 531   tiling clone, Submitted on the opposite strand 531/531
(100 %)
1 diff
(99.9 %id)
CA392350 eye, RPE/choroid .ve 174 to 606 433 to 1     Submitted on the opposite strand 433/433
(100 %)
0 diff
(100 %id)
DB068063 testis .ve 514 to 1042 2 to 530 V16X S17Q C18L D19* tiling clone, capped   529/529
(100 %)
5 diff
(99.1 %id)
BQ881651 dorsal root ganglia .vf 1 to 927 1 to 927   tiling clone,   927/927
(100 %)
7 diff
(99.3 %id)
CV353472 nervous_normal .vf 220 to 774 578 to 19     Submitted on the opposite strand 560/580
(96 %)
0 diff
(100 %id)
DB523210 testis .vf 869 to 1588 1 to 721   tiling clone, Submitted on the opposite strand 721/721
(100 %)
12 diff
(98.4 %id)
TI_149315611   .vf 904 to 1838 1007 to 84   tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 926/976
(94 %)
18 diff
(98.2 %id)
DB636644 testis .vf 931 to 1588 1 to 658   tiling clone, Submitted on the opposite strand 658/658
(100 %)
5 diff
(99.3 %id)
CN272242 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .vf 1061 to 1521 1 to 461       461/461
(100 %)
0 diff
(100 %id)
BQ045470 lung, Primary Lung Cystic Fibrosis EpithelialCells .vf 1131 to 1838 726 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 708/708
(100 %)
0 diff
(100 %id)
BC110652 Placenta, choriocarcinoma .vg 1 to 1969 1 to 1968 exact tiling clone, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 1968/1968
(100 %)
1 diff
(100.0 %id)
BI092421 cervix .vg 2 to 851 1 to 857 exact     857/875
(97 %)
26 diff
(97.1 %id)
BX463210 fetal liver, Liver .vg 27 to 860 1 to 834 G102X P107A F108L L110T R111A ... tiling clone,   834/907
(91 %)
39 diff
(95.8 %id)
BX431961 fetal liver, Liver .vg 524 to 1362 1 to 838       838/838
(100 %)
15 diff
(98.3 %id)
FN107859 breast carcinoma .vh 1 to 57 2 to 58       58/59
(98 %)
2 diff
(96.7 %id)
BC032566 Pancreas, Spleen, adult pooled .vh 1 to 1766 2 to 1761 exact tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1761/1761
(100 %)
7 diff
(99.7 %id)
BI521047 pooled pancreas and spleen .vh 1 to 768 2 to 763 K21M     763/763
(100 %)
3 diff
(99.7 %id)
FN064938 breast carcinoma .vh 3 to 57 56 to 1     Submitted on the opposite strand 56/57
(98 %)
1 diff
(98.3 %id)
CB994706 placenta, pre-eclamptic placenta .vh 3 to 750 27 to 781 exact tiling clone,   755/817
(92 %)
18 diff
(97.8 %id)
AI702689 carcinoid, lung .vh 22 to 299 1 to 278     Submitted on the opposite strand 278/285
(97 %)
1 diff
(99.7 %id)
AI703263 carcinoid, lung .vh 33 to 503 1 to 471     Submitted on the opposite strand 471/471
(100 %)
3 diff
(99.4 %id)
CB270011 adipose .vh 38 to 537 1 to 498       498/498
(100 %)
7 diff
(98.6 %id)
CN368323 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .vh 48 to 252 1 to 205       205/205
(100 %)
0 diff
(100 %id)
CU452853 epidermis .vh 216 to 375 173 to 14     Submitted on the opposite strand 160/176
(90 %)
2 diff
(98.9 %id)
BE067073 breast .vh 336 to 610 10 to 284       275/294
(93 %)
4 diff
(98.7 %id)
AW799980 uterus .vh 337 to 610 7 to 280       274/294
(93 %)
4 diff
(98.7 %id)
AA384654 thyroid gland .vh 501 to 725 1 to 225       225/225
(100 %)
1 diff
(99.6 %id)
BF091410 testis_normal .vh 620 to 994 8 to 380       373/380
(98 %)
6 diff
(98.5 %id)
TI_1948084020   .vh 662 to 881 344 to 125       220/247
(89 %)
0 diff
(100 %id)
FN046087 breast carcinoma .vh 685 to 775 91 to 1     Submitted on the opposite strand 91/91
(100 %)
0 diff
(100 %id)
FN123429 breast carcinoma .vh 713 to 814 1 to 97       97/97
(100 %)
10 diff
(89.7 %id)
BX492078   .vh 777 to 1226 1 to 450       450/450
(100 %)
2 diff
(99.6 %id)
FN062845 breast carcinoma .vh 805 to 856 1 to 51       51/51
(100 %)
1 diff
(98.1 %id)
W26451 eye, retina .vh 947 to 1389 14 to 454   tiling clone,   441/503
(87 %)
17 diff
(96.7 %id)
DB091981 testis .vi 1 to 552 2 to 554 exact tiling clone, capped   553/553
(100 %)
1 diff
(99.9 %id)
DB071433 testis .vi 15 to 553 2 to 540 exact tiling clone, capped   539/539
(100 %)
0 diff
(100 %id)
BI669182 brain, hypothalamus .vj 1 to 516 3 to 518 R24H available from MGC,   518/518
(100 %)
6 diff
(98.9 %id)
TI_44346064   .vj 3 to 516 93 to 606 R24H     514/606
(84 %)
8 diff
(98.7 %id)
BC042852 Brain, hypothalamus .vj 4 to 849 1 to 846 R24H tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 846/848
(99 %)
4 diff
(99.6 %id)
AA973700 carcinoid, lung .vj 22 to 270 1 to 248     Submitted on the opposite strand 248/248
(100 %)
1 diff
(99.6 %id)
AI702457 Kidney .vj 22 to 476 1 to 454     Submitted on the opposite strand 454/454
(100 %)
1 diff
(99.8 %id)
AI652084 pooled germ cell tumors .vj 22 to 476 1 to 455     Submitted on the opposite strand 455/455
(100 %)
1 diff
(99.8 %id)
BE501103 pooled germ cell tumors .vj 22 to 493 1 to 472   tiling clone, Submitted on the opposite strand 472/472
(100 %)
0 diff
(100 %id)
CR739000   .vj 34 to 487 1 to 454       454/454
(100 %)
0 diff
(100 %id)
BP216206 corpus callosum .vj 61 to 568 78 to 587 V96I     587/587
(100 %)
3 diff
(99.5 %id)
BU627157 Bone, Enchondroma cell line .vj 165 to 851 704 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 686/686
(100 %)
1 diff
(99.9 %id)
AI378589 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .vj 314 to 674 361 to 1       361/361
(100 %)
0 diff
(100 %id)
BF093823 uterus .vj 386 to 589 210 to 1       210/212
(99 %)
14 diff
(93.4 %id)
AI367164 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .vj 411 to 674 264 to 1       264/264
(100 %)
3 diff
(98.9 %id)
BQ030152 lung, Metastatic Chondrosarcoma .vj 454 to 851 416 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 398/398
(100 %)
2 diff
(99.5 %id)
BE090566 breast .vj 474 to 760 278 to 564       287/564
(50 %)
6 diff
(99.0 %id)
BQ029782 lung, Metastatic Chondrosarcoma .vj 579 to 851 291 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 273/273
(100 %)
1 diff
(99.7 %id)
AI758381 Kidney .vj 688 to 851 168 to 5       164/168
(97 %)
0 diff
(100 %id)
AK056735 placenta .vk 1 to 1101 2 to 1096 exact tiling clone, available from FLJ,   1096/1096
(100 %)
3 diff
(99.8 %id)
DA835627 placenta .vk 1 to 468 2 to 469 exact capped   468/468
(100 %)
1 diff
(99.8 %id)
AA962553 Kidney .vk 44 to 411 1 to 368   tiling clone, Submitted on the opposite strand 368/368
(100 %)
1 diff
(99.8 %id)
TI_149300902   .vk 395 to 1141 819 to 77   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 743/952
(78 %)
10 diff
(99.0 %id)
CB850878 lung, Primary Lung Cystic Fibrosis EpithelialCells .vk 470 to 1141 690 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 672/672
(100 %)
1 diff
(99.9 %id)
CF455288 peripheral nervous system .vk 492 to 1141 1 to 649   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 649/649
(100 %)
2 diff
(99.7 %id)
CF455265 peripheral nervous system .vk 493 to 1141 36 to 683   tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 648/683
(94 %)
6 diff
(99.2 %id)
DB328203 placenta .vk 559 to 1099 543 to 3       541/543
(99 %)
0 diff
(100 %id)
AW958935   .vk 597 to 1114 1 to 521       521/521
(100 %)
9 diff
(98.3 %id)
BQ268864 Pancreas, Purified pancreatic islet .vk 624 to 1138 515 to 1       515/516
(99 %)
1 diff
(99.9 %id)
BQ268931 Pancreas, Purified pancreatic islet .vk 624 to 1138 515 to 1       515/517
(99 %)
1 diff
(99.9 %id)
AI984027 adenocarcinoma, Pancreas .vk 625 to 1147 526 to 4   tiling clone,   523/526
(99 %)
0 diff
(100 %id)
AI954978 four pooled poorly-differentiatedadenocarcinomas, lung .vk 658 to 1097 446 to 7       440/446
(98 %)
0 diff
(100 %id)
BI821833 pooled brain, lung, testis .vl 1 to 836 6 to 842 A20P K21R M22W G23V R24A ... tiling clone,   842/842
(100 %)
11 diff
(98.7 %id)
TI_57198530   .vl 1 to 836 41 to 877 A20P K21R M22W G23V R24A ...     844/877
(96 %)
18 diff
(98.0 %id)
BG002757 placenta_normal .vm 1 to 575 22 to 600 F9Y T16R F39V T40L I41P ... tiling clone,   579/603
(96 %)
26 diff
(95.7 %id)
DB525714 testis .vn 1 to 716 1 to 717 P22H P23L L30X P34T P36T ... tiling clone, Submitted on the opposite strand 717/717
(100 %)
4 diff
(99.5 %id)
BG192501   .vn 153 to 717 1 to 566       566/584
(96 %)
11 diff
(98.2 %id)
CN368325 embryonic stem cells, DMSO-treated H9 cellline .vo 41 to 394 1 to 354   tiling clone,   354/354
(100 %)
0 diff
(100 %id)
DA958636 Spleen .vo 61 to 555 78 to 566 exact tiling clone, capped   565/565
(100 %)
3 diff
(99.5 %id)
TI_154118452   .vo 396 to 1135 826 to 88       739/1048
(70 %)
30 diff
(97.2 %id)
CA423996 cell lines, Chondrosarcoma .vo 535 to 1132 614 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 596/596
(100 %)
3 diff
(99.5 %id)
BM715850 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .vo 568 to 1134 1 to 567       567/567
(100 %)
1 diff
(99.9 %id)
AW026445 brain, glioblastoma (pooled) .vo 591 to 1139 549 to 1   tiling clone,   549/549
(100 %)
0 diff
(100 %id)
AW439372 serous papillary carcinoma, high grade, 2pooled tumors, uterus .vo 629 to 1130 509 to 8       502/509
(98 %)
0 diff
(100 %id)
AW117707 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .vo 657 to 1088 432 to 1       432/432
(100 %)
3 diff
(99.4 %id)
TI_151734514   .vp 1 to 672 772 to 101 Q2G L26X P73S tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 672/904
(74 %)
6 diff
(99.4 %id)
BQ189693 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .vp 7 to 665 1 to 659   fully sequenced, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 659/659
(100 %)
1 diff
(99.9 %id)
BM457163 embryonal carcinoma, cell line, testis .vp 59 to 678 1 to 620   tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 620/620
(100 %)
0 diff
(100 %id)
CK300816 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .vp 149 to 672 542 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 524/524
(100 %)
3 diff
(99.5 %id)
DB514587 testis .vq 1 to 697 1 to 695 K8N S26X E32K L42F tiling clone, Submitted on the opposite strand 695/699
(99 %)
7 diff
(99.0 %id)
BI559841 testis .vr 1 to 690 1 to 697 E17D E25Q N54K N55Q I56Y ... tiling clone,   697/703
(99 %)
28 diff
(96.1 %id)
DB441931 testis .vr 6 to 330 1 to 325   tiling clone,   325/663
(49 %)
7 diff
(99.0 %id)
TI_44348101   .vr 6 to 690 85 to 776 E17D E25Q N54K N55Q I56Y ...     692/782
(88 %)
28 diff
(96.5 %id)
DA438441 tongue, tumor tissue .vr 59 to 611 2 to 554   tiling clone, capped   553/553
(100 %)
0 diff
(100 %id)
H16982 whole brain .vs 1 to 442 1 to 448 A4X W5G V6* tiling clone,   448/448
(100 %)
9 diff
(98.0 %id)
DB445233 testis .vt -10 to 373 1 to 386 T17N A20D K21Q M22D R24S ... tiling clone,   386/431
(89 %)
5 diff
(98.9 %id)
BG958165 colon .vt 6 to 246 12 to 251   tiling clone,   242/257
(94 %)
11 diff
(95.8 %id)
DB037860 testis .vu 1 to 571 2 to 573   tiling clone, capped   572/572
(100 %)
3 diff
(99.5 %id)
DB048743 testis .vu 1 to 580 2 to 582   capped   581/581
(100 %)
3 diff
(99.5 %id)
BP370585 testis .vu 59 to 610 1 to 552 V58X V70L tiling clone,   552/556
(99 %)
3 diff
(99.5 %id)
AW505498 lymph .vv 1 to 481 21 to 501 exact tiling clone,   487/501
(97 %)
7 diff
(98.7 %id)
TI_154162154   .vv 1 to 694 94 to 783 exact tiling clone,   696/726
(95 %)
31 diff
(95.8 %id)
FN046324 breast carcinoma .vv 90 to 161 1 to 72       72/73
(98 %)
1 diff
(98.7 %id)
AW369625 breast .vw 1 to 529 1 to 526   tiling clone,   526/526
(100 %)
9 diff
(98.3 %id)
AW369686 breast .vw 157 to 791 656 to 24 F16S R17G F18L R19G R20G ... tiling clone,   633/656
(96 %)
6 diff
(99.1 %id)
DB078888 testis .vx 1 to 571 2 to 573 exact tiling clone, capped   572/572
(100 %)
1 diff
(99.9 %id)
DB078968 testis .vx 4 to 571 2 to 569 A45V capped   568/573
(99 %)
3 diff
(99.5 %id)
DB456951.
matches multiple genes
testis .vx 13 to 494 1 to 482   tiling clone, Submitted on the opposite strand, also hits gene CXADR 482/482
(100 %)
1 diff
(99.8 %id)
TI_57183743   .vy 1 to 720 62 to 780 exact     719/780
(92 %)
6 diff
(99.3 %id)
TI_154163223   .vy 1 to 611 78 to 693   tiling clone,   616/712
(86 %)
16 diff
(97.8 %id)
BI767736 pooled lung and spleen .vy 6 to 720 1 to 714 exact tiling clone,   714/714
(100 %)
2 diff
(99.8 %id)
AA399388   .vz 1 to 338 1 to 338 exact tiling clone,   338/338
(100 %)
2 diff
(99.5 %id)
CB048851 Prostate .wa 1 to 460 1 to 461 I2T C3R tiling clone, fully sequenced, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 461/461
(100 %)
13 diff
(97.2 %id)
CB048850 Prostate .wa 168 to 476 339 to 31   tiling clone, fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 309/309
(100 %)
1 diff
(99.7 %id)
BX501008 Liver .wb-u 1 to 650 1 to 648   tiling clone,   648/648
(100 %)
1 diff
(99.9 %id)
BC026295 lung .wb-u 528 to 2906 12 to 2390 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 2379/2392
(99 %)
3 diff
(99.9 %id)
BG570479 lung .wb-u 528 to 1216 13 to 699 L7X available from MGC,   687/699
(98 %)
6 diff
(99.2 %id)
R64260 placenta .wb-u 602 to 914 1 to 315       315/318
(99 %)
3 diff
(99.1 %id)
DA571634 whole embryo, mainly head .wc-u 1 to 803 2 to 804   tiling clone, capped   803/804
(99 %)
4 diff
(99.6 %id)
N94737 multiple sclerosis lesions .wc-u 393 to 819 1 to 426       426/426
(100 %)
2 diff
(99.6 %id)
N94762 multiple sclerosis lesions .wc-u 393 to 835 1 to 443   tiling clone, fully sequenced,   443/443
(100 %)
4 diff
(99.1 %id)
N63469 multiple sclerosis lesions .wc-u 805 to 1349 545 to 1 exact fully sequenced,   545/545
(100 %)
23 diff
(95.8 %id)
EL953046 eyeball .wc-u 833 to 1409 589 to 13 exact tiling clone, Submitted on the opposite strand 577/589
(97 %)
0 diff
(100 %id)
DB358506 whole embryo, mainly head .wc-u 835 to 1392 560 to 1 L16F I17N P18T C19L V20C ...     560/560
(100 %)
6 diff
(99.0 %id)
H96904 melanocyte .wc-u 902 to 1326 436 to 1       436/441
(98 %)
15 diff
(96.6 %id)
N63456 multiple sclerosis lesions .wc-u 948 to 1349 408 to 1       408/411
(99 %)
7 diff
(98.3 %id)
AA533049 normal prostatic epithelial cells, Prostate .wc-u 990 to 1410 426 to 5 C8G tiling clone,   422/430
(98 %)
0 diff
(100 %id)
BX645769   .wd-u 1 to 436 1 to 435 V3* tiling clone,   435/435
(100 %)
3 diff
(99.4 %id)
AI310112 2 pooled tumors (clear cell type), Kidney .wd-u 24 to 471 448 to 1   tiling clone,   448/448
(100 %)
1 diff
(99.8 %id)
AI368822   .wd-u 45 to 469 425 to 1       425/425
(100 %)
2 diff
(99.6 %id)
W84824 liver and spleen .wd-u 384 to 804 1 to 421   tiling clone,   421/421
(100 %)
1 diff
(99.8 %id)
BG900553 cartilage .wd-u 532 to 855 82 to 405   tiling clone,   324/337
(96 %)
6 diff
(98.3 %id)
W84777 liver and spleen .wd-u 931 to 1378 458 to 7   tiling clone,   452/458
(98 %)
0 diff
(100 %id)
BX102246 multiple sclerosis lesions .we-u 1 to 791 1 to 792 L69X tiling clone,   792/792
(100 %)
1 diff
(99.9 %id)
AW947103 lung_tumor .we-u 717 to 1186 477 to 8   tiling clone, Submitted on the opposite strand 470/477
(98 %)
0 diff
(100 %id)
N47078 multiple sclerosis lesions .we-u 720 to 1162 444 to 1   tiling clone,   444/446
(99 %)
3 diff
(99.4 %id)
FN085142 breast carcinoma .we-u 1009 to 1061 53 to 1     Submitted on the opposite strand 53/53
(100 %)
0 diff
(100 %id)
DA393890 thalamus .wf-u 1 to 585 2 to 587   tiling clone, capped   586/586
(100 %)
2 diff
(99.7 %id)
AW450756   .wf-u 379 to 820 449 to 9 exact tiling clone,   441/449
(98 %)
0 diff
(100 %id)
AW373610 breast .wg-u 1 to 416 424 to 6   tiling clone,   419/427
(98 %)
0 diff
(100 %id)
DB307942 hippocampus .wg-u 197 to 738 543 to 1 L63A R64P I65N T67Y W68L ... tiling clone,   543/543
(100 %)
1 diff
(99.9 %id)
DB032156 testis .wh 1 to 470 2 to 471 exact capped   470/470
(100 %)
0 diff
(100 %id)
DB087889 testis .wh 1 to 547 2 to 548 exact tiling clone, capped   547/547
(100 %)
0 diff
(100 %id)
DR001133 fetal brain .wh 9 to 702 32 to 723 exact tiling clone,   692/723
(95 %)
8 diff
(98.9 %id)
DB233918 trachea .wh 13 to 595 2 to 586 exact capped   583/585
(99 %)
5 diff
(99.2 %id)
DB170245 kidney, tumor tissue .wh 49 to 517 2 to 470 S14P capped   469/469
(100 %)
1 diff
(99.8 %id)
BX510229   .wi 1 to 693 1 to 693 exact tiling clone,   693/693
(100 %)
2 diff
(99.8 %id)
AI828064 pooled .wj-u 1 to 516 531 to 16 C24R tiling clone,   516/531
(97 %)
0 diff
(100 %id)
BG191743   .wk-u 1 to 500 1 to 502   tiling clone,   502/502
(100 %)
9 diff
(98.3 %id)
AA707638   .wl 1 to 428 432 to 6 I27T tiling clone,   427/436
(97 %)
1 diff
(99.8 %id)
BF356474 head_neck .wm-u 1 to 294 7 to 299 I4L P7L T8R W9G D10I ... tiling clone,   293/302
(97 %)
12 diff
(96.1 %id)
BG005209 placenta_normal .wn 1 to 218 8 to 222 F2S A4L N5* tiling clone,   215/222
(96 %)
7 diff
(96.9 %id)
TI_1971555219   Gene FLVCR2andTTLL5andC14orf179, variant not shown         Submitted on the opposite strand    
BE147606 head_neck Gene FLVCR2andTTLL5andC14orf179, variant not shown              
BI005031 head_normal Gene FLVCR2andTTLL5andC14orf179, variant not shown              
DA111719 cerebellum Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
DA122036 cerebellum Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
DA166212 amygdala Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
DA299025 hippocampus Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
DA405437 thalamus Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
DA416171 thalamus Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
DA431780 colon Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
BX340137 Placenta Cot 25-normalized Gene FLVCR2andTTLL5andC14orf179, variant not shown              
DA437709 tongue, tumor tissue Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
AL602248   Gene FLVCR2andTTLL5andC14orf179, variant not shown              
BX504029   Gene FLVCR2andTTLL5andC14orf179, variant not shown              
DB449351 testis Gene FLVCR2andTTLL5andC14orf179, variant not shown              
DB449829 testis Gene FLVCR2andTTLL5andC14orf179, variant not shown              
BP243404 Liver Gene FLVCR2andTTLL5andC14orf179, variant not shown              
H16947 whole brain Gene FLVCR2andTTLL5andC14orf179, variant not shown         Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)    
H16948 whole brain Gene FLVCR2andTTLL5andC14orf179, variant not shown       AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)    
H16820 whole brain Gene FLVCR2andTTLL5andC14orf179, variant not shown              
H16928 whole brain Gene FLVCR2andTTLL5andC14orf179, variant not shown              
T73196 Liver Gene FLVCR2andTTLL5andC14orf179, variant not shown              
AA032184 uterus Gene FLVCR2andTTLL5andC14orf179, variant not shown              
AA033658 uterus Gene FLVCR2andTTLL5andC14orf179, variant not shown              
AA148779 uterus Gene FLVCR2andTTLL5andC14orf179, variant not shown              
AA152299 uterus Gene FLVCR2andTTLL5andC14orf179, variant not shown              
BG248171 adenocarcinoma cell line, colon Gene FLVCR2andTTLL5andC14orf179, variant not shown              
BG719012 testis Gene FLVCR2andTTLL5andC14orf179, variant not shown              
BG823772 adenocarcinoma cell line, colon Gene FLVCR2andTTLL5andC14orf179, variant not shown              
CX166969 human embryonic stem cells differentiated toan early endodermal cell type Gene FLVCR2andTTLL5andC14orf179, variant not shown              
CX166885 human embryonic stem cells differentiated toan early endodermal cell type Gene FLVCR2andTTLL5andC14orf179, variant not shown              
DR158993 human embryonic stem cells differentiated toan early endodermal cell type Gene FLVCR2andTTLL5andC14orf179, variant not shown              
DA619235   Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
DA715711   Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
DA722117   Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
DA744586   Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
DA756923   Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
DA759969   Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
DA760459   Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
DB325753 brain Gene FLVCR2andTTLL5andC14orf179, variant not shown              
DA771392 brain Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
DA809217 brain Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
DA811123 brain Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
DA924885 small intestine Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
BM146750 leukopheresis Gene FLVCR2andTTLL5andC14orf179, variant not shown              
DB063007 testis Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
DB065168 testis Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
DB069958 testis Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
DB073306 testis Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
DB076606 testis Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
DB084160 testis Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
DB093646 testis Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
DB093964 testis Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
DB095772 testis Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
DB096425 testis Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
DB100653 testis Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
DB180744 kidney, tumor tissue Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
DB181446 liver, tumor tissue Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
DB184381 liver, tumor tissue Gene FLVCR2andTTLL5andC14orf179, variant not shown       capped      
DB347641 liver, tumor tissue Gene FLVCR2andTTLL5andC14orf179, variant not shown              
BU733407 eye, optic nerve Gene FLVCR2andTTLL5andC14orf179, variant not shown       AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)    
TI_151770184   Gene FLVCR2andTTLL5andC14orf179, variant not shown              
71 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve, .vf, .vg, .vh, .vi, .vj, .vk, .vl, .vm, .vn, .vo, .vp, .vq, .vr, .vs, .vt, .vu, .vv, .vw, .vx, .vy, .vz, .wa, .wb-u, .wc-u, .wd-u, .we-u, .wf-u, .wg-u, .wh, .wi, .wj-u, .wk-u, .wl, .wm-u, .wn Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI